Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia - Episode 5

Real-World Safety Data for BTK Inhibitors in CLL from EHA 2024

,

Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss real-world safety data for BTK inhibitors in chronic lymphocytic leukemia from EHA 2024.